Androgens are thought to cause prostate cancer, but the precise mechanisms by which they do so are unclear.
Data, mostly from animal studies, suggest that for androgens to cause prostate cancer they must be aromatized to estrogen and act in concert with these estrogen metabolites. Androgen-receptor mediated activity of androgens and estrogen receptor-mediated effects of estrogen metabolites are likely to be necessary, but estrogen genotoxicity appears to be a probable critical factor as well. Only when all these mechanisms are active, may prostate carcinogenesis result. Convincing proof-of-concept studies are needed to definitively test this concept which, if proven, may lead to clinically feasible chemoprevention approaches interfering with these mechanisms.
Written by:
Bosland MC. Are you the author?
Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA.
Reference: Cancer Lett. 2012 Aug 29. pii: S0304-3835(12)00515-0.
doi: 10.1016/j.canlet.2012.08.027
PubMed Abstract
PMID: 22939996
UroToday.com Investigative Urology Section
